Chief Operating Officer
Tracey Worthington-Stice is the Chief Operating Officer (COO) of ArunA Biomedical. Under her direction, ArunA was the first to commercialize human neural stem cells derived from human pluripotent stem cells and is now prepared to model a new class of cell-free biologics, specifically exosomes, with the potential to modify outcomes CNS damage, and neural degenerative diseases.
Ms. Worthington-Stice brings over 14 years of experience in the biotechnology industry and has held senior positions in executive management, business development, marketing, and operations. Her strength is in building quality and operations systems, influence and awareness, and value positioning. In the late ‘90s, while working at Advanced Cell Technology, headquartered in Worcester, Massachusetts, Ms. Worthington-Stice made key introductions to stakeholders by aligning the Company’s narrative with the parallel effort of an integrated communications strategy to meet the priorities of a joint collaboration, worth $10 million with Genzyme Transgenics.
Currently, she is the Chairperson of the Athens-Clarke County Hospital Authority, serves on the Board of Directors of Piedmont Athens Regional Medical Center, and is an active member on the Quality Committee at Piedmont Athens Regional Health System. She is also former Chair of the Georgia Bioscience Joint Development Authority and member of The Mayor’s Task Force on Economic Development. Ms. Worthington-Stice earned a Bachelor of Arts with a focus in organizational development from the University of Massachusetts.